InsiderClue
Insiders · Profile

Johnson David Michael

Director at Aura Biosciences · Director at Zentalis Pharmaceuticals. Filing since 7 Apr 2020. CIK 0001808098

AURA Aura Biosciences, Inc. Director · 15 trades ZNTL Zentalis Pharmaceuticals, Inc. Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AURA Aura Biosciences, Inc.
16 May 2025
Director
Bought
20,000
$98.00K
13.7%
ZNTL Zentalis Pharmaceuticals, Inc.
10 Nov 2023
Director
Bought
17,000
$167.94K
13.3%
AURA Aura Biosciences, Inc.
8 Nov 2023
Director
Bought
20,000
$146.00K
36.4%
AURA Aura Biosciences, Inc.
8 Nov 2023
Director
Bought
9,601
$70.09K
7.6%
AURA Aura Biosciences, Inc.
7 Nov 2023
Director
Bought
94,000
$673.98K
opened
AURA Aura Biosciences, Inc.
7 Nov 2023
Director
Bought
76,000
$544.92K
152%
AURA Aura Biosciences, Inc.
4 Oct 2023
Director
Bought
6,566
$56.51K
15.1%
AURA Aura Biosciences, Inc.
3 Oct 2023
Director
Bought
13,500
$111.66K
45.0%
AURA Aura Biosciences, Inc.
6 Jan 2023
Director
Bought
1,604
$16.85K
9.8%
AURA Aura Biosciences, Inc.
5 Jan 2023
Director
Bought
396
$3.96K
2.3%
AURA Aura Biosciences, Inc.
28 Dec 2022
Director
Bought
4,000
$39.00K
30.8%
AURA Aura Biosciences, Inc.
1 Dec 2022
Director
Bought
10,000
$123.70K
200%
AURA Aura Biosciences, Inc.
13 Jun 2022
Director
Bought
20,000
$279.80K
200%
AURA Aura Biosciences, Inc.
13 Jun 2022
Director
Bought
14,000
$195.86K
opened
AURA Aura Biosciences, Inc.
10 Jun 2022
Director
Bought
10,000
$150.40K
opened
AURA Aura Biosciences, Inc.
10 Jun 2022
Director
Bought
6,000
$90.24K
opened
ZNTL Zentalis Pharmaceuticals, Inc.
4 Oct 2021
Director
Sold, plan not stated
12,896
$855.59K
13.7%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Apr 2021
Director
Sold, plan not stated
12,897
$561.02K
12.7%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Dec 2020
Director
Sold, plan not stated
12,896
$662.75K
11.2%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Apr 2020
Director
Bought
4,000
$72.00K
3.6%
20 decisions on file.